Blue Light Headset for Nocturnal Uterine Contraction Regulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods fail to effectively regulate uterine contractions during nocturnal hours in pregnant females, particularly in preterm labor, due to the lack of understanding and control over circadian signals driving uterine activity.

Innovation Solution

Exposing pregnant females to a light source emitting visible light, specifically with sufficient intensity and blue light spectrum, to suppress endogenous melatonin levels, thereby reducing or preventing nocturnal uterine contractions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If light exposure is applied to suppress melatonin levels, then uterine contraction frequency is reduced, but the complexity of the intervention increases

Engineering Contradiction:
Improvecontraction frequencyVSAvoidintervention complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent replaces complex pharmacological interventions with a simpler optical intervention. Instead of administering drugs to suppress melatonin and reduce contractions, the invention uses light exposure (phototherapy) to achieve the same physiological effect, substituting a mechanical/optical system for a chemical/pharmacological system.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If light therapy is used to regulate nocturnal contractions, then preterm labor is delayed, but the treatment requires precise control of light parameters

Engineering Contradiction:
Improvelabor regulation effectivenessVSAvoidlight parameter control
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies phototherapy by changing specific parameters of light exposure: intensity (lux levels), spectral composition (blue light wavelength), and timing (nocturnal hours). By optimizing these parameters, the treatment achieves reliable suppression of melatonin and reduction of uterine contractions, delaying preterm labor while maintaining a relatively simple intervention protocol.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If melatonin suppression is achieved through light exposure, then nocturnal uterine activity is reduced, but the mechanism requires understanding of circadian biology

Engineering Contradiction:
Improveuterine activity reductionVSAvoidcircadian mechanism complexity
Core Design Contradiction:
ProductivityVSDifficulty of detecting and measuring

Solution Approach 1:

The patent uses light as an intermediary to modulate the circadian system. By applying photic stimuli during nocturnal hours, the treatment indirectly suppresses melatonin production through the circadian pacemaker, which in turn reduces uterine contractility. This intermediary approach leverages the natural circadian regulation of both melatonin and uterine activity, providing a physiologically-based treatment mechanism.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The suppression of melatonin levels leads to a significant decrease in uterine contractions, potentially prolonging pregnancy or delaying preterm birth, as demonstrated by clinical experiments showing a direct correlation between light exposure and reduced contractions.

Implementation Method 1

Exposing pregnant females to light during nocturnal hours decreases their endogenous melatonin levels, which regulates nocturnal uterine contractions

Methodology Applied
Scientific EffectMelatonin suppression by light exposure: Photoelectric Effect

Data Source

PatentUS10118050B2Using light to regulate uterine contractions
Publication Date: 2018.11.06 FLORIDA STATE UNIV RES FOUND INC
  • US10118050B2 patent drawing
  • US10118050B2 patent drawing
  • US10118050B2 patent drawing

AI summary

A method of regulating uterine contractions comprises suppressing a nocturnal endogenous melatonin level of a pregnant female experiencing uterine contractions at night by exposing the pregnant female during nighttime to a light source emitting blue light. The light source may be a headset. The contractions may be measured while the female is exposed to the blue light.